Position in BNTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$507,437,249
-$57,440,898 QoQ
Shares Held
5,709,240
-3.8% QoQ
Ownership
2.26%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.27897583566289.ToString("F0")%
Shared 0.ToString("F0")%
None 0.7210241643371097.ToString("F0")%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,674,888,413 across 352 Biotechnology names. BNTX ranks #27 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in BNTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $507,437,249 | 5,709,240 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $564,878,147 | 5,933,594 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $537,822,196 | 5,453,480 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $868,689,899 | 8,159,011 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $663,227,404 | 7,283,411 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $877,583,188 | 7,701,476 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $748,242,564 | 6,299,929 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $56,391,743 | 701,739 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $76,972,476 | 834,390 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $14,455,178 | 136,964 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $25,839,371 | 237,844 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $24,545,654 | 227,422 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $28,419,896 | 228,144 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $27,422,960 | 182,552 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $35,656,200 | 264,355 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $63,183,657 | 423,767 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $213,554,080 | 1,252,076 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $84,693,486 | 328,524 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $484,199,357 | 1,773,689 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $447,091,269 | 1,997,013 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $191,535,201 | 1,754,146 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $236,302,430 | 2,898,705 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $311,727,735 | 4,502,784 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $681,469,725 | 10,210,814 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $43,110,003 | 738,185 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||